Fibrosis Models
Welcome to MLM Medical Labs, your premier partner for unraveling the complexities of fibrosis and its critical implications for various medical conditions. Fibrosis, characterized by excessive tissue scarring and stiffening, is a hallmark feature in numerous diseases, profoundly impacting patient health and quality of life.
At MLM Medical Labs, we pride ourselves on our extensive expertise in deciphering the nuances of fibrosis across a spectrum of conditions. Our research and insights delve deep into the intricate mechanisms underlying fibrosis progression, offering invaluable knowledge to the medical community.
Explore our specialized in vivo models that delve into fibrosis
in the following diseases:
In IPF, the progressive scarring of lung tissues poses significant challenges to respiratory function.
Investigate our enhanced Idiopathic pulmonary fibrosis model.
MASH (formerly known as NASH) is a growing concern globally, with liver fibrosis being a critical determinant of disease progression.
Delve into our studies deciphering fibrotic transformations in liver tissue, connecting metabolic factors to hepatic fibrosis.
More information on MLM’s MASH models
Systemic sclerosis, also known as scleroderma, presents unique challenges due to its systemic nature and widespread fibrotic manifestations.
MLM’s multidisciplinary approach explores the complex interplay of immune dysregulation and fibrosis affecting not only the lungs but the skin as well.
More information on MLM’s systemic sclerosis models
Innovation drives our pursuit of excellence in fibrosis research. We are committed to partnering with YOU to pioneer new models and methodologies to better mimic disease pathology, accelerating your drug discovery and development processes.
Our novel approaches offer fresh perspectives and breakthrough opportunities in combating fibrosis-related disorders.
Click here to find out more about our co-development programs.
